相关实验视频
Updated: Sep 14, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
357
"美学医学中的干扰:使用间歇平衡框架对GLP-1激动剂的全球分析"
Eqram Rahman1, William Richard Webb1, Shabnam Sadeghi Esfahlani2
1Research and Innovation Hub, Innovation Aesthetics, London UK.
Plastic and reconstructive surgery
|July 21, 2025
概括
用于代谢健康的葡萄糖类-1 (GLP-1) 疗法可能会导致"Ozempic face",导致对化品填充剂的需求增加. 社交媒体影响者经常宣传这些填充剂,引发了对基于证据的患者护理的伦理担忧.
科学领域:
- 代谢医学是一种代谢医学.
- 审美医学是一种美学医学.
- 社交媒体分析
背景情况:
- 葡萄糖类-1 (GLP-1) 受体激活剂显著促进肥胖和2型糖尿病治疗.
- 意外的面部体积损失,称为"Ozempic面部",在美容医学中提出了一个挑战.
- 代谢治疗和美学关注之间的相互作用造成了伦理困境,并依赖皮肤填充剂等干预措施.
研究的目的:
- 分析GLP-1疗法对美容医学的影响.
- 调查公众的看法和影响者在促进美学干预中的作用.
- 评估"Ozempic脸"和纠正治疗的伦理影响.
主要方法:
- 一种混合方法的方法,结合内容分析,社交媒体情绪分析和社交网络建模.
- 分析了15项同行评审的研究和临床报告.
- 全球对379万条社交媒体帖子进行了审查,以评估公众情绪和影响者活动.
主要成果:
- 与GLP-1治疗副作用相关的填充剂咨询增加了40%.
- 72%的高参与度的社交媒体内容推广填充剂是受影响者驱动的,将它们作为附加剂正常化.
- 由于商业叙述,亚洲和南美洲的伦理问题加剧,与北美和欧洲更受监管的方法形成鲜明对比.
结论:
- GLP-1疗法带来了美学,伦理和心理方面的挑战.
- 社交媒体的商业影响可以掩盖基于证据的实践.
- 监管改革,进一步的研究和患者教育对于管理这些不断变化的问题和确保患者福祉至关重要.
相关概念视频
01:24Glucagon-like Receptor Agonists
421
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
421
01:23Dipeptidyl Peptidase 4 Inhibitors
262
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
262
01:28Global Regulatory Systems
74
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
74